We present an optimized protocol to enhance the transcription factor profiling in human tumor tissue and successfully performed ChIP-seq for ERα, AR, and FOXA1 in primary breast, endometrium, and prostate cancer specimens. The gene discussed is ESR1; the disease is prostate carcinoma.